Concepedia

Daniel N. Cohen

DN

Statistics

Publications

20

Citations

1.1K

H-Index

18

Active since

1971

Affiliations

Bristol-Myers Squibb (United States)(Current)

Vanderbilt University Medical Center

Purdue University West Lafayette

University of Minnesota

Baylor College of Medicine

Daniel N. Cohen is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and life sciences.

ORCID

Publications per year

1971–2023

20

Publications

20

Synthesis and Biologic Evaluation of a Novel <sup>18</sup>F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression

David J. Donnelly, R. Adam Smith, Paul E. Morin et al. · Journal of Nuclear Medicine · 2017 · 192 citations · Full text

, , +17

Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy

Douglas B. Johnson, Erika Wallender, Daniel N. Cohen et al. · Cancer Immunology Research · 2013 · 103 citations · Full text

, , +17

Structures of Adnectin/Protein Complexes Reveal an Expanded Binding Footprint

Vidhyashankar Ramamurthy, Stanley R. Krystek, Alexander A. Bush et al. · Structure · 2012 · 89 citations · Full text

, , +17

Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates

Erin L. Cole, Joon‐Young Kim, David J. Donnelly et al. · Bioorganic & Medicinal Chemistry · 2017 · 88 citations

, , +14

Mapping the Energetic Epitope of an Antibody/Interleukin-23 Interaction with Hydrogen/Deuterium Exchange, Fast Photochemical Oxidation of Proteins Mass Spectrometry, and Alanine Shave Mutagenesis

Jing Li, Hui Wei, Stanley R. Krystek et al. · Analytical Chemistry · 2017 · 86 citations · Full text

, , +17

1–5 of 20